Related Experiment Videos
Summary
Systemic lupus erythematosus (SLE) in Bulgaria shows varied progression. Early onset and rapid complications indicate a poor prognosis, while later onset is linked to milder disease courses and better survival rates.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Context:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with variable clinical manifestations and progression.
- Understanding disease evolution in specific populations, like Bulgaria, is crucial for tailored patient management.
- This study investigates the long-term outcomes of SLE in a cohort of Bulgarian patients.
Purpose:
- To analyze the clinical course and prognostic factors of systemic lupus erythematosus (SLE) in the Bulgarian population.
- To identify differences in disease onset, duration, complications, and mortality among SLE patient subgroups.
- To compare the characteristics of patients with subclinical, classical, and severe SLE.
Summary:
- A 44-month follow-up of 172 Bulgarian SLE patients revealed three distinct disease trajectories: subclinical (32 patients), classical (62 patients), and severe with poor prognosis (78 patients).
- Patients with unfavorable prognoses experienced earlier disease onset (p < 0.001), faster development of severe signs (p < 0.001), and more frequent, severe complications, with 25 deaths in this group.
- Conversely, favorable outcomes were associated with later onset, longer disease duration, milder complications, and no mortality.
Impact:
- This research highlights key indicators for predicting SLE prognosis within the Bulgarian context.
- Findings can inform clinical practice by enabling earlier identification of high-risk patients and guiding therapeutic strategies.
- The study contributes valuable epidemiological data on SLE progression in Eastern Europe.